Harriet Millward, deputychiefexecutive of the Alzheimer's Research Trust, said the research was very exciting, but cautioned that it would not be a complete cure for Alzheimer's.
Simon Wigglesworth, deputychiefexecutive of Epilepsy Action, said more research was needed, particularly given the "small sample size and the inconsistencies in the data collected".